Pfizer Recalls Norpace CR Capsules Due to Dissolution Failure
Pfizer recalls Norpace CR extended-release capsules due to failed dissolution specifications. Check lot numbers C150064 and C150065 for expiration date 6/16.
Use caution until it’s fixed
Failed Dissolution Specification
Contact the company
What happened, in plain English
Pfizer Inc. is recalling specific lots of Norpace CR (disopyramide phosphate) extended-release capsules, 150 mg, because they failed dissolution specifications. This means the medication may not release or work as intended. The affected products are distributed by G.D. Searle LLC. Read more at govinfonow.com/recall/43349-pfizer-inc-recalls-norpace-cr-disopyramide-phosphate-extended-release-capsules.
Source Summary by GovInfoNow · govinfonow.com/recall/43349-pfizer-inc-recalls-norpace-cr-disopyramide-phosphate-extended-release-capsules · Updated October 11, 2026 · FDA enforcement record: FDA #D-0520-2016
Cite this page
“Pfizer Recalls Norpace CR Capsules Due to Dissolution Failure.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43349-pfizer-inc-recalls-norpace-cr-disopyramide-phosphate-extended-release-capsules. Based on FDA recall #D-0520-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0520-2016%22&limit=1).
Why it’s dangerous
The capsules failed to meet dissolution specifications, which could result in the drug not being released properly into the body. This failure may lead to the medication not working as expected for the patient.
Who’s affected
Patients currently taking Norpace CR extended-release capsules who purchased bottles with lot numbers C150064 or C150065 and an expiration date of June 2016.
How to tell if you have this one
Look for Norpace CR (disopyramide phosphate) extended-release capsules USP, 150 mg. Check the bottle for lot numbers C150064 or C150065 and an expiration date of 6/16. The product is Rx only and distributed by G.D. Searle LLC.
- Brand
Pfizer- Category
Drug
What to do — step by step
Check Your Medication
Verify if your Norpace CR capsules match the recalled lot numbers C150064 or C150065 with an expiration date of June 2016.
Contact Your Pharmacist
Speak with your healthcare provider or pharmacist to determine the appropriate next steps for your treatment.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0520-2016 (December 2, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0520-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.